ArticleBMC nephrology2022

Extension of Tablo TrEatmeNt Duration (XTEND) study: successful 24 h prolonged therapy with Tablo in critical patients.

Tahir Zaman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.